المؤلفون: Herbst, SA, Vesterlund, M, Helmboldt, AJ, Jafari, R, Siavelis, I, Stahl, M, Schitter, EC, Liebers, N, Brinkmann, BJ, Czernilofsky, F, Roider, T, Bruch, PM, Iskar, M, Kittai, A, Huang, Y, Lu, JY, Richter, S, Mermelekas, G, Umer, HM, Knoll, M, Kolb, C, Lenze, A, Cao, XF, Osterholm, C, Wahnschaffe, L, Herling, C, Scheinost, S, Ganzinger, M, Mansouri, L, Kriegsmann, K, Kriegsmann, M, Anders, S, Zapatka, M, Del Poeta, G, Zucchetto, A, Bomben, R, Gattei, V, Dreger, P, Woyach, J, Herling, M, Muller-Tidow, C, Rosenquist, R, Stilgenbauer, S, Zenz, T, Huber, W, Tausch, E, Lehtio, J, Dietrich, S

المصدر: Nature communications. 13(1):6226

مصطلحات موضوعية: Medicin och hälsovetenskap

URL الوصول: http://kipublications.ki.se/Default.aspx?queryparsed=id:151016511

المؤلفون: Tkocz Hp, Werner Schmidt, S. Schwaiger, Breitbach Gp, Bruch Pm

المصدر: Geburtshilfe und Frauenheilkunde. 50:816-818

مصطلحات موضوعية: medicine.medical_specialty, business.industry, medicine.medical_treatment, Complete remission, Obstetrics and Gynecology, Uvea, medicine.disease, The primary diagnosis, Metastasis, Surgery, Radiation therapy, Remission induction, Breast cancer, medicine.anatomical_structure, Maternity and Midwifery, Medicine, business, After treatment

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::b855e6bf976daeb56ba52d12de88924d
https://doi.org/10.1055/s-2008-1026371

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Brinkmann BJ; Department of Medicine V, Hematology, Oncology and Rheumatology, University of Heidelberg, Heidelberg, Germany.; Molecular Medicine Partnership Unit, Heidelberg, Germany.; Genome Biology, European Molecular Biology Laboratory, Heidelberg, Germany.; Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center, Heidelberg, Germany.; Faculty of Biosciences, University of Heidelberg, Heidelberg, Germany., Floerchinger A; Faculty of Biosciences, University of Heidelberg, Heidelberg, Germany.; Molecular Genetics, German Cancer Research Center, Heidelberg, Germany., Schniederjohann C; Department of Medicine V, Hematology, Oncology and Rheumatology, University of Heidelberg, Heidelberg, Germany.; Molecular Medicine Partnership Unit, Heidelberg, Germany.; Faculty of Biosciences, University of Heidelberg, Heidelberg, Germany.; Department of Hematology, Oncology and Clinical Immunology, University Hospital Düsseldorf, Düsseldorf, Germany.; Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf, Düsseldorf, Germany., Roider T; Department of Medicine V, Hematology, Oncology and Rheumatology, University of Heidelberg, Heidelberg, Germany.; Molecular Medicine Partnership Unit, Heidelberg, Germany.; Genome Biology, European Molecular Biology Laboratory, Heidelberg, Germany., Coelho M; Faculty of Biosciences, University of Heidelberg, Heidelberg, Germany.; Molecular Genetics, German Cancer Research Center, Heidelberg, Germany., Mack N; Molecular Genetics, German Cancer Research Center, Heidelberg, Germany., Bruch PM; Department of Medicine V, Hematology, Oncology and Rheumatology, University of Heidelberg, Heidelberg, Germany.; Molecular Medicine Partnership Unit, Heidelberg, Germany.; Department of Hematology, Oncology and Clinical Immunology, University Hospital Düsseldorf, Düsseldorf, Germany.; Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf, Düsseldorf, Germany., Liebers N; Department of Medicine V, Hematology, Oncology and Rheumatology, University of Heidelberg, Heidelberg, Germany.; Molecular Medicine Partnership Unit, Heidelberg, Germany.; Department of Hematology, Oncology and Clinical Immunology, University Hospital Düsseldorf, Düsseldorf, Germany.; Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf, Düsseldorf, Germany.; Department of Translational Medical Oncology, National Center for Tumor Diseases, Heidelberg, Germany., Dötsch S; Institute for Medical Microbiology, Immunology and Hygiene, Technical University of Munich, Munich, Germany., Busch DH; Institute for Medical Microbiology, Immunology and Hygiene, Technical University of Munich, Munich, Germany.; German Center for Infection Research, Partner Site Munich, Munich, Germany., Schmitt M; Department of Medicine V, Hematology, Oncology and Rheumatology, University of Heidelberg, Heidelberg, Germany.; German Cancer Consortium and German Cancer Research Center/National Center for Tumor Diseases, Heidelberg, Germany., Neumann F; Department of Hematology, Oncology and Clinical Immunology, University Hospital Düsseldorf, Düsseldorf, Germany., Roessner PM; Molecular Genetics, German Cancer Research Center, Heidelberg, Germany., Seiffert M; Molecular Genetics, German Cancer Research Center, Heidelberg, Germany., Dietrich S; Department of Medicine V, Hematology, Oncology and Rheumatology, University of Heidelberg, Heidelberg, Germany.; Molecular Medicine Partnership Unit, Heidelberg, Germany.; Genome Biology, European Molecular Biology Laboratory, Heidelberg, Germany.; Department of Hematology, Oncology and Clinical Immunology, University Hospital Düsseldorf, Düsseldorf, Germany.; Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf, Düsseldorf, Germany.

المصدر: Blood [Blood] 2024 Aug 15; Vol. 144 (7), pp. 784-789.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

مواضيع طبية MeSH: Leukemia, Lymphocytic, Chronic, B-Cell*/immunology , Leukemia, Lymphocytic, Chronic, B-Cell*/therapy , Leukemia, Lymphocytic, Chronic, B-Cell*/pathology , Antigens, CD19*/immunology , Antigens, CD20*/immunology , Antibodies, Bispecific*/therapeutic use , Immunotherapy, Adoptive*/methods, Animals ; Mice ; Humans ; T-Lymphocytes/immunology ; Receptors, Chimeric Antigen/immunology ; Xenograft Model Antitumor Assays

المؤلفون: Roessner PM; Division of Molecular Genetics, German Cancer Research Center, Heidelberg, Germany., Seufert I; Division of Chromatin Networks, German Cancer Research Center and BioQuant, Heidelberg, Germany.; Faculty of Biosciences, University of Heidelberg, Heidelberg, Germany., Chapaprieta V; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain., Jayabalan R; Division of Molecular Genetics, German Cancer Research Center, Heidelberg, Germany.; Faculty of Biosciences, University of Heidelberg, Heidelberg, Germany., Briesch H; Division of Molecular Genetics, German Cancer Research Center, Heidelberg, Germany.; Faculty of Biosciences, University of Heidelberg, Heidelberg, Germany., Massoni-Badosa R; Division of Molecular Genetics, German Cancer Research Center, Heidelberg, Germany.; Single Cell Genomics, Centre for Genomic Regulation, Barcelona Institute of Science and Technology, Barcelona, Spain., Boskovic P; Division of Molecular Genetics, German Cancer Research Center, Heidelberg, Germany.; Faculty of Biosciences, University of Heidelberg, Heidelberg, Germany., Benckendorff J; Department of Pathology, University Hospital Ulm, Ulm, Germany., Roider T; Department of Medicine V, Heidelberg University Hospital, Heidelberg, Germany.; Molecular Medicine Partnership Unit, Heidelberg, Germany., Arseni L; Division of Molecular Genetics, German Cancer Research Center, Heidelberg, Germany., Coelho M; Division of Molecular Genetics, German Cancer Research Center, Heidelberg, Germany.; Faculty of Biosciences, University of Heidelberg, Heidelberg, Germany., Chakraborty S; Molecular Hematology, International Centre for Genetic Engineering and Biotechnology, Trieste, Italy., Vaca AM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Sivina M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Muckenhuber M; Division of Chromatin Networks, German Cancer Research Center and BioQuant, Heidelberg, Germany., Rodriguez-Rodriguez S; Department of Hematology, City of Hope National Medical Center, Duarte, CA., Bonato A; Molecular Hematology, International Centre for Genetic Engineering and Biotechnology, Trieste, Italy., Herbst SA; Department of Medicine V, Heidelberg University Hospital, Heidelberg, Germany.; Molecular Medicine Partnership Unit, Heidelberg, Germany., Zapatka M; Division of Molecular Genetics, German Cancer Research Center, Heidelberg, Germany., Sun C; Laboratory of Lymphoid Malignancies, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD., Kretzmer H; Department of Genome Regulation, Max Planck Institute for Molecular Genetics, Berlin, Germany., Naake T; Genome Biology Unit, European Molecular Biology Laboratory, Heidelberg, Germany., Bruch PM; Department of Medicine V, Heidelberg University Hospital, Heidelberg, Germany.; Molecular Medicine Partnership Unit, Heidelberg, Germany.; Department of Hematology, Oncology and Clinical Immunology, University Hospital Düsseldorf, Düsseldorf, Germany., Czernilofsky F; Department of Medicine V, Heidelberg University Hospital, Heidelberg, Germany.; Molecular Medicine Partnership Unit, Heidelberg, Germany., Ten Hacken E; Department of Medicine, Weill Cornell Medicine, New York, NY., Schneider M; Proteomics Core Facility, German Cancer Research Center, Heidelberg, Germany., Helm D; Proteomics Core Facility, German Cancer Research Center, Heidelberg, Germany., Yosifov DY; Division of Chronic Lymphocytic Leukemia, Department of Internal Medicine III, Ulm University, Ulm, Germany.; Cooperation Unit Mechanisms of Leukemogenesis, German Cancer Research Center, Heidelberg, Germany., Kauer J; Department of Medicine V, Heidelberg University Hospital, Heidelberg, Germany.; Molecular Medicine Partnership Unit, Heidelberg, Germany., Danilov AV; Department of Hematology, City of Hope National Medical Center, Duarte, CA., Bewarder M; José Carreras Center for Immuno- and Gene Therapy and Internal Medicine I, Saarland University Medical School, Homburg/Saar, Germany., Heyne K; José Carreras Center for Immuno- and Gene Therapy and Internal Medicine I, Saarland University Medical School, Homburg/Saar, Germany., Schneider C; Division of Chronic Lymphocytic Leukemia, Department of Internal Medicine III, Ulm University, Ulm, Germany., Stilgenbauer S; Division of Chronic Lymphocytic Leukemia, Department of Internal Medicine III, Ulm University, Ulm, Germany., Wiestner A; Laboratory of Lymphoid Malignancies, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD., Mallm JP; Division of Chromatin Networks, German Cancer Research Center and BioQuant, Heidelberg, Germany., Burger JA; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Efremov DG; Molecular Hematology, International Centre for Genetic Engineering and Biotechnology, Trieste, Italy., Lichter P; Division of Molecular Genetics, German Cancer Research Center, Heidelberg, Germany., Dietrich S; Department of Medicine V, Heidelberg University Hospital, Heidelberg, Germany.; Molecular Medicine Partnership Unit, Heidelberg, Germany.; Department of Hematology, Oncology and Clinical Immunology, University Hospital Düsseldorf, Düsseldorf, Germany., Martin-Subero JI; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.; Institució Catalana de Recerca i Estudis Avançats, Barcelona, Spain., Rippe K; Division of Chromatin Networks, German Cancer Research Center and BioQuant, Heidelberg, Germany., Seiffert M; Division of Molecular Genetics, German Cancer Research Center, Heidelberg, Germany.

المصدر: Blood [Blood] 2024 Aug 01; Vol. 144 (5), pp. 510-524.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

مواضيع طبية MeSH: Leukemia, Lymphocytic, Chronic, B-Cell*/pathology , Leukemia, Lymphocytic, Chronic, B-Cell*/genetics , Leukemia, Lymphocytic, Chronic, B-Cell*/immunology , Leukemia, Lymphocytic, Chronic, B-Cell*/metabolism , T-Box Domain Proteins*/genetics , T-Box Domain Proteins*/metabolism , Cell Proliferation*, Animals ; Humans ; Mice ; B-Lymphocytes/pathology ; B-Lymphocytes/metabolism ; B-Lymphocytes/immunology ; Mice, Knockout ; Gene Expression Regulation, Leukemic ; NF-kappa B/metabolism

المؤلفون: Schmitt L; Institute for Molecular Medicine I, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Universitätsstraße 1, 40225, Düsseldorf, Germany., Hoppe J; Institute for Molecular Medicine I, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Universitätsstraße 1, 40225, Düsseldorf, Germany., Cea-Medina P; Institute for Pharmaceutical and Medicinal Chemistry, Faculty of Mathematics and Natural Sciences, Heinrich Heine University Düsseldorf, Universitätsstraße 1, 40225, Düsseldorf, Germany., Bruch PM; Department of Hematology, Oncology and Clinical Immunology, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Moorenstraße 5, 40225, Düsseldorf, Germany.; Department of Medicine V, Heidelberg University Hospital, Heidelberg, Germany.; Molecular Medicine Partnership Unit (MMPU), Heidelberg, Germany.; Center for Integrated Oncology Aachen-Bonn-Cologne-Düsseldorf (CIO ABCD), Düsseldorf, Germany., Krings KS; Institute for Molecular Medicine I, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Universitätsstraße 1, 40225, Düsseldorf, Germany., Lechtenberg I; Institute for Molecular Medicine I, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Universitätsstraße 1, 40225, Düsseldorf, Germany., Drießen D; Institute of Organic Chemistry and Macromolecular Chemistry, Faculty of Mathematics and Natural Sciences, Heinrich Heine University Düsseldorf, Universitätsstraße 1, 40225, Düsseldorf, Germany., Peter C; Institute for Molecular Medicine I, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Universitätsstraße 1, 40225, Düsseldorf, Germany., Bhatia S; Department of Pediatric Oncology, Hematology and Clinical Immunology, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Moorenstraße 5, 40225, Düsseldorf, Germany., Dietrich S; Department of Hematology, Oncology and Clinical Immunology, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Moorenstraße 5, 40225, Düsseldorf, Germany.; Department of Medicine V, Heidelberg University Hospital, Heidelberg, Germany.; Molecular Medicine Partnership Unit (MMPU), Heidelberg, Germany.; Center for Integrated Oncology Aachen-Bonn-Cologne-Düsseldorf (CIO ABCD), Düsseldorf, Germany., Stork B; Institute for Molecular Medicine I, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Universitätsstraße 1, 40225, Düsseldorf, Germany., Fritz G; Institute of Toxicology, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Universitätsstraße 1, 40225, Düsseldorf, Germany., Gohlke H; Institute for Pharmaceutical and Medicinal Chemistry, Faculty of Mathematics and Natural Sciences, Heinrich Heine University Düsseldorf, Universitätsstraße 1, 40225, Düsseldorf, Germany.; John von Neumann Institute for Computing (NIC), Jülich Supercomputing Center (JSC) and Institute of Bio- and Geosciences (IBG-4: Bioinformatics), Forschungszentrum Jülich GmbH, Wilhelm-Johnen-Straße, 52425, Jülich, Germany., Müller TJJ; Institute of Organic Chemistry and Macromolecular Chemistry, Faculty of Mathematics and Natural Sciences, Heinrich Heine University Düsseldorf, Universitätsstraße 1, 40225, Düsseldorf, Germany., Wesselborg S; Institute for Molecular Medicine I, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Universitätsstraße 1, 40225, Düsseldorf, Germany. sebastian.wesselborg@uni-duesseldorf.de.; Center for Integrated Oncology Aachen-Bonn-Cologne-Düsseldorf (CIO ABCD), Düsseldorf, Germany. sebastian.wesselborg@uni-duesseldorf.de.

المصدر: Cell death discovery [Cell Death Discov] 2024 Jun 11; Vol. 10 (1), pp. 279. Date of Electronic Publication: 2024 Jun 11.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: United States NLM ID: 101665035 Publication Model: Electronic Cited Medium: Print ISSN: 2058-7716 (Print) Linking ISSN: 20587716 NLM ISO Abbreviation: Cell Death Discov Subsets: PubMed not MEDLINE

المؤلفون: Rius Rigau A; Department of Internal Medicine 3, Rheumatology and Clinical Immunology (A.R.R., G.S., J.H.W.D., M.L.), Friedrich-Alexander-University Erlangen-Nürnberg and University Hospital Erlangen, Germany.; Deutsches Zentrum Immuntherapie (A.R.R., G.S., J.H.W.D., M.L.), Friedrich-Alexander-University Erlangen-Nürnberg and University Hospital Erlangen, Germany., Li YN; Clinic for Rheumatology (Y.-N.L., A.-E.M., A.-H.G., V.D., A.G., J.H.W.D., M.L.), University Hospital Düsseldorf, Medical Faculty of Heinrich Heine University, Germany.; Hiller Research Center (Y.-N.L., A.-E.M., A.-H.G., V.D., A.G., J.H.W.D., M.L.), University Hospital Düsseldorf, Medical Faculty of Heinrich Heine University, Germany., Matei AE; Clinic for Rheumatology (Y.-N.L., A.-E.M., A.-H.G., V.D., A.G., J.H.W.D., M.L.), University Hospital Düsseldorf, Medical Faculty of Heinrich Heine University, Germany.; Hiller Research Center (Y.-N.L., A.-E.M., A.-H.G., V.D., A.G., J.H.W.D., M.L.), University Hospital Düsseldorf, Medical Faculty of Heinrich Heine University, Germany., Györfi AH; Clinic for Rheumatology (Y.-N.L., A.-E.M., A.-H.G., V.D., A.G., J.H.W.D., M.L.), University Hospital Düsseldorf, Medical Faculty of Heinrich Heine University, Germany.; Hiller Research Center (Y.-N.L., A.-E.M., A.-H.G., V.D., A.G., J.H.W.D., M.L.), University Hospital Düsseldorf, Medical Faculty of Heinrich Heine University, Germany., Bruch PM; Department of Haematology, Oncology and Clinical Immunology, University Hospital Düsseldorf, Germany (P.-M.B., S.K., S.D.).; Center for Integrated Oncology Aachen-Bonn-Cologne-Düsseldorf, Aachen Bonn Cologne, Germany (P.-M.B., S.K., S.D.).; Molecular Medicine Partnership Unit, Heidelberg, Germany (P.-M.B., S.K., S.D.).; Department of Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Germany (P.-M.B., S.D.)., Koziel S; Department of Haematology, Oncology and Clinical Immunology, University Hospital Düsseldorf, Germany (P.-M.B., S.K., S.D.).; Center for Integrated Oncology Aachen-Bonn-Cologne-Düsseldorf, Aachen Bonn Cologne, Germany (P.-M.B., S.K., S.D.).; Molecular Medicine Partnership Unit, Heidelberg, Germany (P.-M.B., S.K., S.D.).; Düsseldorf School of Oncology, Germany (S.K.)., Devakumar V; Clinic for Rheumatology (Y.-N.L., A.-E.M., A.-H.G., V.D., A.G., J.H.W.D., M.L.), University Hospital Düsseldorf, Medical Faculty of Heinrich Heine University, Germany.; Hiller Research Center (Y.-N.L., A.-E.M., A.-H.G., V.D., A.G., J.H.W.D., M.L.), University Hospital Düsseldorf, Medical Faculty of Heinrich Heine University, Germany., Gabrielli A; Clinic for Rheumatology (Y.-N.L., A.-E.M., A.-H.G., V.D., A.G., J.H.W.D., M.L.), University Hospital Düsseldorf, Medical Faculty of Heinrich Heine University, Germany.; Hiller Research Center (Y.-N.L., A.-E.M., A.-H.G., V.D., A.G., J.H.W.D., M.L.), University Hospital Düsseldorf, Medical Faculty of Heinrich Heine University, Germany.; Fondazione di Medicina Molecolare e Terapia Cellulare, Università Politecnica delle Marche, Ancona, Italy (A.G.)., Kreuter A; Department of Dermatology, Venerology and Allergology, Helios St. Johannes Klinik Duisburg, Germany (A.K.).; Department of Dermatology, Venerology and Allergology, Helios St. Elisabeth Klinik Oberhausen, University Witten-Herdecke, Germany (A.K.)., Wang J; Department of Rheumatology, Huashan Hospital (J.W., M.L.), Fudan University, Shanghai, P. R. China.; State Key Laboratory of Genetic Engineering, Collaborative Innovation Center for Genetics and Development, School of Life Sciences, and Human Phenome Institute, Fudan University, Shanghai, P. R. China (J.W.).; Research Unit of Dissecting the Population Genetics and Developing New Technologies for Treatment and Prevention of Skin Phenotypes and Dermatological Diseases (2019RU058), Chinese Academy of Medical Sciences, Shanghai, P. R. China (J.W.)., Dietrich S; Department of Haematology, Oncology and Clinical Immunology, University Hospital Düsseldorf, Germany (P.-M.B., S.K., S.D.).; Center for Integrated Oncology Aachen-Bonn-Cologne-Düsseldorf, Aachen Bonn Cologne, Germany (P.-M.B., S.K., S.D.).; Molecular Medicine Partnership Unit, Heidelberg, Germany (P.-M.B., S.K., S.D.).; Department of Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Germany (P.-M.B., S.D.)., Schett G; Department of Internal Medicine 3, Rheumatology and Clinical Immunology (A.R.R., G.S., J.H.W.D., M.L.), Friedrich-Alexander-University Erlangen-Nürnberg and University Hospital Erlangen, Germany.; Deutsches Zentrum Immuntherapie (A.R.R., G.S., J.H.W.D., M.L.), Friedrich-Alexander-University Erlangen-Nürnberg and University Hospital Erlangen, Germany., Distler JHW; Department of Internal Medicine 3, Rheumatology and Clinical Immunology (A.R.R., G.S., J.H.W.D., M.L.), Friedrich-Alexander-University Erlangen-Nürnberg and University Hospital Erlangen, Germany.; Deutsches Zentrum Immuntherapie (A.R.R., G.S., J.H.W.D., M.L.), Friedrich-Alexander-University Erlangen-Nürnberg and University Hospital Erlangen, Germany.; Clinic for Rheumatology (Y.-N.L., A.-E.M., A.-H.G., V.D., A.G., J.H.W.D., M.L.), University Hospital Düsseldorf, Medical Faculty of Heinrich Heine University, Germany.; Hiller Research Center (Y.-N.L., A.-E.M., A.-H.G., V.D., A.G., J.H.W.D., M.L.), University Hospital Düsseldorf, Medical Faculty of Heinrich Heine University, Germany., Liang M; Department of Internal Medicine 3, Rheumatology and Clinical Immunology (A.R.R., G.S., J.H.W.D., M.L.), Friedrich-Alexander-University Erlangen-Nürnberg and University Hospital Erlangen, Germany.; Deutsches Zentrum Immuntherapie (A.R.R., G.S., J.H.W.D., M.L.), Friedrich-Alexander-University Erlangen-Nürnberg and University Hospital Erlangen, Germany.; Clinic for Rheumatology (Y.-N.L., A.-E.M., A.-H.G., V.D., A.G., J.H.W.D., M.L.), University Hospital Düsseldorf, Medical Faculty of Heinrich Heine University, Germany.; Hiller Research Center (Y.-N.L., A.-E.M., A.-H.G., V.D., A.G., J.H.W.D., M.L.), University Hospital Düsseldorf, Medical Faculty of Heinrich Heine University, Germany.; Department of Rheumatology, Huashan Hospital (J.W., M.L.), Fudan University, Shanghai, P. R. China.; Huashan Rare Disease Center (M.L.), Fudan University, Shanghai, P. R. China.

المصدر: Circulation research [Circ Res] 2024 Mar 29; Vol. 134 (7), pp. 875-891. Date of Electronic Publication: 2024 Mar 05.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0047103 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1524-4571 (Electronic) Linking ISSN: 00097330 NLM ISO Abbreviation: Circ Res Subsets: MEDLINE

مواضيع طبية MeSH: Scleroderma, Systemic*/complications , Scleroderma, Systemic*/pathology , Endothelial Progenitor Cells*, Humans ; Proteomics ; Fibrosis ; Myofibroblasts/pathology

المؤلفون: Roider T; Department of Medicine V, Hematology, Oncology and Rheumatology, University of Heidelberg, Heidelberg, Germany.; Molecular Medicine Partnership Unit, Heidelberg, Germany.; European Molecular Biology Laboratory, Heidelberg, Germany., Baertsch MA; Department of Medicine V, Hematology, Oncology and Rheumatology, University of Heidelberg, Heidelberg, Germany.; Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA, USA., Fitzgerald D; Department of Medicine V, Hematology, Oncology and Rheumatology, University of Heidelberg, Heidelberg, Germany.; Molecular Medicine Partnership Unit, Heidelberg, Germany.; European Molecular Biology Laboratory, Heidelberg, Germany., Vöhringer H; Department of Medicine V, Hematology, Oncology and Rheumatology, University of Heidelberg, Heidelberg, Germany.; Molecular Medicine Partnership Unit, Heidelberg, Germany.; European Molecular Biology Laboratory, Heidelberg, Germany., Brinkmann BJ; Department of Medicine V, Hematology, Oncology and Rheumatology, University of Heidelberg, Heidelberg, Germany.; Molecular Medicine Partnership Unit, Heidelberg, Germany.; European Molecular Biology Laboratory, Heidelberg, Germany.; Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center, Heidelberg, Germany., Czernilofsky F; Department of Medicine V, Hematology, Oncology and Rheumatology, University of Heidelberg, Heidelberg, Germany.; Molecular Medicine Partnership Unit, Heidelberg, Germany.; European Molecular Biology Laboratory, Heidelberg, Germany., Knoll M; European Molecular Biology Laboratory, Heidelberg, Germany., Llaó-Cid L; Division of Molecular Genetics, German Cancer Research Center, Heidelberg, Germany.; Molecular Pathology of Lymphoid Neoplasms, Fundació de Recerca Clinic Barcelona-Institut d'Investigacions Biomèdiques August Pi i Sunyer (FRCB-IDIBAPS), Barcelona, Spain., Mathioudaki A; European Molecular Biology Laboratory, Heidelberg, Germany., Faßbender B; Department of Hematology and Oncology, University Hospital Düsseldorf, Düsseldorf, Germany., Herbon M; Department of Hematology and Oncology, University Hospital Düsseldorf, Düsseldorf, Germany., Lautwein T; Genomics and Transcriptomics Laboratory, University of Düsseldorf, Düsseldorf, Germany., Bruch PM; Department of Medicine V, Hematology, Oncology and Rheumatology, University of Heidelberg, Heidelberg, Germany.; Molecular Medicine Partnership Unit, Heidelberg, Germany.; European Molecular Biology Laboratory, Heidelberg, Germany.; Department of Hematology and Oncology, University Hospital Düsseldorf, Düsseldorf, Germany., Liebers N; European Molecular Biology Laboratory, Heidelberg, Germany.; Department of Hematology and Oncology, University Hospital Düsseldorf, Düsseldorf, Germany.; National Center for Tumor Diseases, Heidelberg, Germany.; German Cancer Research Center, Heidelberg, Germany., Schürch CM; Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA, USA.; Department of Pathology and Neuropathology, University Hospital and Comprehensive Cancer Center Tübingen, Tübingen, Germany., Passerini V; Department of Medicine III, Laboratory for Experimental Leukemia and Lymphoma Research, Ludwig-Maximilians-University Hospital, Munich, Germany., Seifert M; Department of Hematology and Oncology, University Hospital Düsseldorf, Düsseldorf, Germany., Brobeil A; Department of Pathology, University of Heidelberg, Heidelberg, Germany., Mechtersheimer G; Department of Pathology, University of Heidelberg, Heidelberg, Germany., Müller-Tidow C; Department of Medicine V, Hematology, Oncology and Rheumatology, University of Heidelberg, Heidelberg, Germany.; Molecular Medicine Partnership Unit, Heidelberg, Germany., Weigert O; German Cancer Research Center, Heidelberg, Germany.; Department of Medicine III, Laboratory for Experimental Leukemia and Lymphoma Research, Ludwig-Maximilians-University Hospital, Munich, Germany.; German Cancer Consortium, Munich, Germany., Seiffert M; Division of Molecular Genetics, German Cancer Research Center, Heidelberg, Germany., Nolan GP; Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA., Huber W; Molecular Medicine Partnership Unit, Heidelberg, Germany. wolfgang.huber@embl.de.; European Molecular Biology Laboratory, Heidelberg, Germany. wolfgang.huber@embl.de., Dietrich S; Department of Medicine V, Hematology, Oncology and Rheumatology, University of Heidelberg, Heidelberg, Germany. sascha.dietrich@embl.de.; Molecular Medicine Partnership Unit, Heidelberg, Germany. sascha.dietrich@embl.de.; European Molecular Biology Laboratory, Heidelberg, Germany. sascha.dietrich@embl.de.; Department of Hematology and Oncology, University Hospital Düsseldorf, Düsseldorf, Germany. sascha.dietrich@embl.de.; Center for Integrated Oncology Aachen-Bonn-Cologne-Düsseldorf (CIO ABCD), Aachen Bonn Cologne Düsseldorf, Germany. sascha.dietrich@embl.de.

المصدر: Nature cell biology [Nat Cell Biol] 2024 Mar; Vol. 26 (3), pp. 478-489. Date of Electronic Publication: 2024 Feb 20.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Macmillan Magazines Ltd Country of Publication: England NLM ID: 100890575 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-4679 (Electronic) Linking ISSN: 14657392 NLM ISO Abbreviation: Nat Cell Biol Subsets: MEDLINE

مواضيع طبية MeSH: T-Lymphocytes*/pathology , Lymphoma, B-Cell, Marginal Zone*/pathology, Humans ; B-Lymphocytes/pathology ; Transforming Growth Factor beta ; Tumor Microenvironment

المؤلفون: Liebers N; Department of Hematology, Oncology and Clinical Immunology, University Hospital Düsseldorf, Düsseldorf, Germany.; Department of Medicine V, Heidelberg University Hospital, Heidelberg, Germany.; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Molecular Medicine Partnership Unit (MMPU), Heidelberg, Germany.; Center for Integrated Oncology Aachen-Bonn-Cologne-Düsseldorf (CIO ABCD), Aachen Bonn Cologne Düsseldorf, Germany., Bruch PM; Department of Hematology, Oncology and Clinical Immunology, University Hospital Düsseldorf, Düsseldorf, Germany.; Department of Medicine V, Heidelberg University Hospital, Heidelberg, Germany.; Molecular Medicine Partnership Unit (MMPU), Heidelberg, Germany.; Center for Integrated Oncology Aachen-Bonn-Cologne-Düsseldorf (CIO ABCD), Aachen Bonn Cologne Düsseldorf, Germany., Terzer T; Division of Biostatistics, German Cancer Research Center (DKFZ), Heidelberg, Germany., Hernandez-Hernandez M; Department of Medicine V, Heidelberg University Hospital, Heidelberg, Germany., Paramasivam N; Computational Oncology Group, Molecular Precision Oncology Program, NCT Heidelberg and DKFZ, Heidelberg, Germany., Fitzgerald D; Department of Medicine V, Heidelberg University Hospital, Heidelberg, Germany.; Molecular Medicine Partnership Unit (MMPU), Heidelberg, Germany.; European Molecular Biology Laboratory (EMBL), Heidelberg, Germany., Altmann H; University Hospital TU Dresden, Dresden, Germany., Roider T; Department of Medicine V, Heidelberg University Hospital, Heidelberg, Germany., Kolb C; Department of Medicine V, Heidelberg University Hospital, Heidelberg, Germany., Knoll M; Department of Medicine V, Heidelberg University Hospital, Heidelberg, Germany., Lenze A; Department of Medicine V, Heidelberg University Hospital, Heidelberg, Germany., Platzbecker U; Leipzig University Hospital, Leipzig, Germany., Röllig C; University Hospital TU Dresden, Dresden, Germany., Baldus C; Department of Internal Medicine II, University Hospital of Kiel, Kiel, Germany., Serve H; Department of Internal Medicine II, University Hospital of Frankfurt Main, Frankfurt am Main, Germany., Bornhäuser M; University Hospital TU Dresden, Dresden, Germany., Hübschmann D; Computational Oncology Group, Molecular Precision Oncology Program, NCT Heidelberg and DKFZ, Heidelberg, Germany.; Heidelberg Institute for Stem Cell Technology and Experimental Medicine, Heidelberg, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany., Müller-Tidow C; Department of Medicine V, Heidelberg University Hospital, Heidelberg, Germany.; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Molecular Medicine Partnership Unit (MMPU), Heidelberg, Germany., Stölzel F; Department of Internal Medicine II, University Hospital of Kiel, Kiel, Germany., Huber W; Molecular Medicine Partnership Unit (MMPU), Heidelberg, Germany.; European Molecular Biology Laboratory (EMBL), Heidelberg, Germany., Benner A; Division of Biostatistics, German Cancer Research Center (DKFZ), Heidelberg, Germany., Zenz T; Department of Medical Oncology and Hematology, Universitätsspital & Universität Zürich, Zürich, Switzerland.; The LOOP Zürich-Medical Research Center, Zürich, Switzerland., Lu J; Molecular Medicine Partnership Unit (MMPU), Heidelberg, Germany.; European Molecular Biology Laboratory (EMBL), Heidelberg, Germany.; Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany., Dietrich S; Department of Hematology, Oncology and Clinical Immunology, University Hospital Düsseldorf, Düsseldorf, Germany. sascha.dietrich@embl.de.; Department of Medicine V, Heidelberg University Hospital, Heidelberg, Germany. sascha.dietrich@embl.de.; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany. sascha.dietrich@embl.de.; Molecular Medicine Partnership Unit (MMPU), Heidelberg, Germany. sascha.dietrich@embl.de.; Center for Integrated Oncology Aachen-Bonn-Cologne-Düsseldorf (CIO ABCD), Aachen Bonn Cologne Düsseldorf, Germany. sascha.dietrich@embl.de.; European Molecular Biology Laboratory (EMBL), Heidelberg, Germany. sascha.dietrich@embl.de.; Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany. sascha.dietrich@embl.de.

المصدر: Nature cancer [Nat Cancer] 2023 Dec; Vol. 4 (12), pp. 1648-1659. Date of Electronic Publication: 2023 Oct 02.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101761119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2662-1347 (Electronic) Linking ISSN: 26621347 NLM ISO Abbreviation: Nat Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Hematologic Neoplasms*/drug therapy , Hematologic Neoplasms*/genetics , Leukemia, Myeloid, Acute*/drug therapy , Leukemia, Myeloid, Acute*/genetics, Humans ; Cytarabine/therapeutic use ; Daunorubicin/therapeutic use ; Prospective Studies ; Antibiotics, Antineoplastic/therapeutic use ; Antimetabolites, Antineoplastic/therapeutic use ; Treatment Outcome